STOCK TITAN

December 2022 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of December 2022 Every stock ranked by its December 2022 gain, with or without news

100

Ranked gains

+1007.59%

Largest, AMAM

86.9%

Above baseline, day +5

0.6%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in December 2022

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 AMAM +1007.59% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment

08:00 ET premarket

2 PHVS +356.57% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks

06:50 ET premarket

3 MDGL +268.07% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th

16:00 ET after hours

4 SMMT +194.27% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody

07:30 ET premarket

5 RXDX More than one ranked move this month 2+ ranked moves +165.67% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb

07:00 ET premarket

6 HOTH Also on the opposite board this month on both boards +143.64% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

08:45 ET premarket

7 MAXR +124.81% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Maxar Technologies To Be Acquired by Advent International for $6.4 Billion

07:00 ET premarket

8 ICVX +112.38% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Icosavax Reports Positive Durability Data for VLP Vaccine Candidate IVX-121 Against RSV at Six-Month Timepoint

16:05 ET after hours

9 VLON +104.69% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators

16:05 ET after hours

10 SLNO +103.86% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Soleno Therapeutics Announces Financing Commitment for up to $60 Million

08:00 ET premarket

11 ISO Same release as rank 55 +102.87% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

16:15 ET after hours

12 TIG +91.51% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Trean Insurance Group Announces Definitive Agreement to be Acquired by Altaris Capital Partners

08:00 ET premarket

13 RENT +74.26% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Rent the Runway, Inc. Announces Third Quarter 2022 Results & Raises Guidance

16:01 ET after hours

14 CORZ Also on the opposite board this month on both boards +69.72% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury B. RILEY FINANCIAL ISSUES OPEN LETTER TO CORE SCIENTIFIC INVESTORS

13:58 ET intraday

15 PRQR +63.64% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership catalyst from a later release the same session ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

06:15 ET premarket

16 PALI +61.49% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Palisade Bio Announces $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules

08:45 ET premarket

17 ORIC +59.67% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer

17:48 ET after hours

18 PAFO +59.01% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Pacifico Acquisition Corp. Stockholders Approve Proposed Merger Transaction with Caravelle

17:00 ET after hours

19 REKR +56.45% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution (terminated) Rose on dilution Rekor Terminates "At-The-Market" Facility

13:00 ET intraday

20 FFIE Also on the opposite board this month on both boards +55.53% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Faraday Future to Host Virtual Global Investor Business Update on Thursday, December 15th, 2022

23:00 ET after hours

21 RNA +55.28% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Avidity Announces Positive AOC 1001 Phase 1/2 MARINA™ Data Demonstrating First-Ever Successful Targeted Delivery of RNA to Muscle - Revolutionary Advancement for the Field of RNA Therapeutics

07:00 ET premarket

22 GRRR +47.25% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Gorilla Technology Group Wraps up Successful 2022 by Entering MENA Region with Security Convergence Offering in Multi-Year, Multi-Million Dollar Deal

17:00 ET after hours

23 MFH release reads negative +45.59% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 45.59% Mercurity Fintech Holding Inc. Reports First Half 2022 Financial Results

08:30 ET premarket

24 CPHI release reads negative +44.38% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition catalyst from a later release the same session Release reads negative, stock rose 44.38% China Pharma Announces Receipt of Noncompliance Notice from NYSE American

16:10 ET after hours

25 IMBIL +43.23% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition iMedia Brands Signs Agreement to Sell Three Buildings For $48 Million

16:00 ET after hours

26 VOR +41.86% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million

07:45 ET premarket

27 IPHA +39.47% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

01:00 ET premarket

28 KINS +39.45% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Kingstone Announces Exchange Agreement for Debt Refinancing

08:00 ET premarket

29 EXPR +38.28% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Express, Inc. Reports Third Quarter 2022 Results

06:00 ET premarket

30 VRNA +37.81% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-1 Trial of Nebulized Ensifentrine for COPD

16:01 ET after hours

31 BYSI +35.94% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BeyondSpring Presents Positive Data with Plinabulin for the Prevention of Docetaxel-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer and Breast Cancer at Three Medical Conferences

08:00 ET premarket

32 AVXL Also on the opposite board this month on both boards +35.85% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease

20:26 ET after hours

33 CFMS +35.00% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule

16:30 ET after hours

34 COSM Also on the opposite board this month on both boards +34.49% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company

15:10 ET intraday

35 EH More than one ranked move this month 2+ ranked moves +34.27% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change EHang Holdings Limited Announces Appointment of Nick Ning Yang as New Independent Director

07:27 ET premarket

36 JNCE +33.79% against the close of 12/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Gilead To Acquire All Remaining Rights To Potential First-In-Class Immunotherapy GS-1811 From Jounce Therapeutics

16:30 ET after hours

37 WVE +32.69% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets

07:30 ET premarket

38 VVNT +32.37% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition NRG Energy, Inc. to Acquire Vivint Smart Home, Inc.

06:01 ET premarket

39 SLNH Also on the opposite board this month on both boards +31.57% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Soluna Receives Green Light from Regulator for Flagship Texas Data Center

08:30 ET premarket

40 LANV +31.06% against the close of 12/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Lanvin Group Debuts on NYSE under Ticker "LANV"

16:30 ET after hours

41 NAAS +30.10% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change NaaS Technology Inc. Announces Appointment of Alex Wu as Chief Financial Officer, President and Director

07:56 ET premarket

42 LASE +29.64% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Laser Photonics Receives Order From The Largest Glass Manufacturer In North America

07:00 ET premarket

43 FORA +29.36% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement New York Selects BioTrack as the State's Cannabis Track and Trace System

18:37 ET after hours

44 MOMO +29.33% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2022

01:23 ET premarket

45 ACLX +29.24% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

08:15 ET premarket

46 POL release reads negative +28.07% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Release reads negative, stock rose 28.07% Polished.com Announces Internal Investigation Results, Corporate Updates and the Board of Directors’ Remedial Actions

08:00 ET premarket

47 IFRX +27.96% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19

07:30 ET premarket

48 DGICB +27.35% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend Donegal Group Inc. Announces Quarterly Dividend

15:57 ET intraday

49 COUP +26.67% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Coupa Software Enters into Definitive Agreement to Be Acquired by Thoma Bravo for $8 Billion

07:00 ET premarket

50 SPB +26.62% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Spectrum Brands’ Statement on ASSA ABLOY’s Proposed Sale of its Emtek and Smart Residential Business in the U.S. and Canada

00:15 ET premarket

51 OKTA release reads negative +26.46% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads negative, stock rose 26.46% Okta Announces Third Quarter Fiscal Year 2023 Financial Results

16:01 ET after hours

52 CELC +26.36% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer

16:00 ET after hours

53 FLNC +26.34% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Fluence Energy, Inc. Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results  

17:15 ET after hours

54 ARCE +25.77% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Arco Announces Receipt of Non-Binding Going Private Proposal

20:43 ET after hours

55 BLI Same release as rank 11 +24.69% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

16:15 ET after hours

56 TAYD +24.07% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings TAYLOR DEVICES ANNOUNCES SECOND QUARTER AND SIX-MONTH RESULTS

08:52 ET premarket

57 CIH +23.72% against the close of 12/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership China Index Holdings Enters into Definitive Agreement for Going-Private Transaction

07:50 ET premarket

58 LIAN +23.70% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

07:00 ET premarket

59 ZYME +23.59% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership catalyst from a later release the same session Zymeworks Announces Participation in Upcoming Investor Conference

07:30 ET premarket

60 HYMC +23.48% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement HYCROFT CONTINUES DRILLING HIGHER GRADES

08:00 ET premarket

61 IMMX +23.29% against the close of 12/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloidosis (100% Complete Responses)

08:00 ET premarket

62 WEBR +23.23% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Weber Inc. to Be Taken Private by BDT Capital Partners for $8.05 Per Share

07:16 ET premarket

63 MDB +23.23% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings MongoDB, Inc. Announces Third Quarter Fiscal 2023 Financial Results

16:05 ET after hours

64 TGB +23.20% against the close of 12/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership TASEKO AND MITSUI ENTER STRATEGIC PARTNERSHIP TO DEVELOP FLORENCE COPPER

08:30 ET premarket

65 ARBK Also on the opposite board this month on both boards +23.19% against the close of 12/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Argo Blockchain PLC Announces Closing of Transactions - Galaxy Digital Holdings

02:00 ET premarket

66 CAMP +22.74% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CalAmp Reports Third Quarter Fiscal Year 2023 Financial Results

16:05 ET after hours

67 HARP +22.61% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma

10:00 ET intraday

68 FOA +22.50% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Finance of America to Acquire Assets of Reverse Mortgage Lender AAG

07:00 ET premarket

69 NILE +22.50% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Ault Alpha Has Purchased 50 Million Shares of Common Stock of BitNile Holdings, Inc.

06:30 ET premarket

70 HILS +22.36% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targets

08:47 ET premarket

71 RXDX More than one ranked move this month 2+ ranked moves +22.35% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock

16:01 ET after hours

72 CERE +22.33% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial

06:30 ET premarket

73 REPL +22.23% against the close of 12/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update

07:00 ET premarket

74 DBVT +22.03% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial  

01:30 ET premarket

75 SFT +21.90% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Shift Closes Merger with CarLotz, Creating a Differentiated Used Omnichannel Auto Retailer, and Announces Shift Board of Directors Changes

09:00 ET premarket

76 RIGL +21.84% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Rigel Announces U.S. FDA Approval of REZLIDHIA™ (olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation

17:03 ET after hours

77 OTLK +21.81% against the close of 12/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note

09:00 ET premarket

78 DLNG +21.29% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Dynagas LNG Partners LP Announces New Time Charter for the LNG Carrier Arctic Aurora

09:00 ET premarket

79 BXRX +20.77% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery

08:00 ET premarket

80 SESN +20.67% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger

16:33 ET after hours

81 KSCP +20.59% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Knightscope (Nasdaq: KSCP) Receives 5 New Contracts

09:40 ET intraday

82 MICT +20.46% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition MICT Completes Acquisition of Operating Business and Assets of Tingo, Inc.

09:05 ET premarket

83 ONCY +20.45% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Oncolytics Biotech® Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer

09:37 ET intraday

84 BSGM +20.28% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology

08:30 ET premarket

85 SIG +20.25% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings SIGNET JEWELERS REPORTS THIRD QUARTER FISCAL 2023 RESULTS

06:50 ET premarket

86 IOT +20.20% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Samsara Reports Third Quarter Fiscal 2023 Financial Results

16:15 ET after hours

87 EH More than one ranked move this month 2+ ranked moves +20.17% against the close of 12/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings EHang Reports Third Quarter 2022 Unaudited Financial Results

05:00 ET premarket

88 CIEN +19.96% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Ciena Reports Fiscal Fourth Quarter 2022 and Year-End Financial Results

07:00 ET premarket

89 POWL +19.78% against the close of 12/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings POWELL INDUSTRIES ANNOUNCES FISCAL 2022 FOURTH QUARTER AND FULL YEAR RESULTS

16:15 ET after hours

90 MRNA +19.63% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA(R) (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial

07:00 ET premarket

91 SQNS +19.42% against the close of 12/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Sequans Announces Conference Call to Review Fourth Quarter and Year-End 2022 Results

06:00 ET premarket

92 YEXT +19.32% against the close of 11/30/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Yext, Inc. Announces Third Quarter Fiscal 2023 Results

16:05 ET after hours

93 YMTX +19.19% against the close of 12/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta

07:30 ET premarket

94 DAKT Also on the opposite board this month on both boards +19.19% against the close of 12/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Daktronics, Inc. Announces 2023 Fiscal Second Quarter Results, Details Liquidity Enhancement Program

07:30 ET premarket

95 SBET +19.18% against the close of 12/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings SharpLink Gaming Announces Results of Extraordinary General Meeting of Shareholders

08:30 ET premarket

96 PPTA +18.62% against the close of 12/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Perpetua Resources Receives Critical Minerals Award of up to $24.8 million under the Defense Production Act

07:00 ET premarket

97 TRDA Also on the opposite board this month on both boards +18.51% against the close of 12/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)

07:00 ET premarket

98 JOUT +18.38% against the close of 12/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Johnson Outdoors Reports Fiscal 2022 Results

06:00 ET premarket

99 MDIA +18.27% against the close of 12/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend MediaCo Holding Inc. Announces Share Repurchase Program

08:04 ET premarket

100 MMMB +18.25% against the close of 12/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings MamaMancini’s Reports Third Quarter 2023 Financial Results

16:05 ET after hours

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 451 smaller events this month are held out of this month's eligible pool; switch to include them. 226 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

2 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

2 events were left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2022, the median gainer had given back 0.6% of its move five sessions later; the largest catalyst group was Earnings, 20 of the 100 events, at a median of +21.3%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Earnings 20 20.0% +21.3% +25.7% 90.0% of 20
Other Announcement 18 18.0% +28.0% +17.0% of 17 76.5% of 17
M&A / Acquisition 16 16.0% +29.5% +25.5% 93.8% of 16
Contract / Partnership 15 15.0% +28.0% +34.6% 100.0% of 15
Clinical Trial Results 13 13.0% +35.9% +47.8% 76.9% of 13

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

7 other catalyst types, 18 events: Offering / Dilution, FDA & Regulatory, Leadership Change, Buyback / Dividend, Crypto & Treasury, Reverse Merger / Shell, Uplisting / Compliance.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 97.0% of 99 0.5% further above baseline, of 99
Day +5 86.9% of 99 0.6% given back, of 99
Month end 82.6% of 92 0.4% further above baseline, of 92
Month end falls before day +5 for 9 of these 92 events, so this row is not a later horizon than the one above it. 92 of the 100 events have a month-end close later than the measured session; 6 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2022

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
RXDX 2Clinical Trial Results, Offering / Dilution +165.67%
EH 2Leadership Change, Earnings +34.27%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
PALIthis month too 2022-11, 2022-09 +81.90%
PETQ 2022-11, 2022-09 +36.36%
PRVB 2022-11, 2022-10 +26.09%
ISEE 2022-11, 2022-09 +66.31%
AKUS 2022-10, 2022-09 +88.16%
NUVL 2022-10, 2022-09 +60.64%
NTNX 2022-10, 2022-09 +29.13%
USEA 2022-10, 2022-09 +20.99%
RETA 2022-10, 2022-09 +21.06%
LITM 2022-10, 2022-09 +38.26%
TC 2022-10, 2022-09 +19.06%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market62.0%
  • Intraday7.0%
  • After hours31.0%

Volume against normal

  • Under 5x20 events, 20.4%
  • 5x to 20x31 events, 31.6%
  • Over 20x47 events, 48.0%

2 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations17 events, 17.0%
  • Biological Products, (no Diagnostic Substances)8 events, 8.0%
  • Finance Services3 events, 3.0%
  • Miscellaneous Electrical Machinery, Equipment & Supplies3 events, 3.0%
  • Communications Equipment, Nec2 events, 2.0%
  • Fire, Marine & Casualty Insurance2 events, 2.0%

17 other industries, 20 events

Industry not known: 45.0%

4 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against November 2022

100 events in the comparable window.

November 2022 median +31.2%, selected from the 10,091 events in that month's eligible pool

December 2022 median +26.5%, 4.7 points below November 2022. December 2022's median is taken over the 100 ranked rows, selected from the 5,910 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.